[6] Preclinical studies in animal models suggest that GLP-1 receptor activation may: Promote neuroplasticity and neurogenesis (formation of new neurons) in the hippocampus, a region often showing reduced volume in depression Modulate neurotransmitter systems , particularly dopamine and serotonin pathways involved in mood regulation and reward processing Reduce neuroinflammation , which is increasingly recognised as contributing to depressive disorders Enhance brain-derived neurotrophic factor (BDNF) expression, a protein crucial for neuronal health and resilience Metabolic improvements associated with GLP-1 therapy may also contribute indirectly to mood benefits
Efficacy and safety of semaglutide in a diabetic and obese patient on incremental hemodialysis
extrathyroidal tumor extension was non-significantly associated with GLP-1R expression (OR, 3.46
More clinical data and research are needed to fully understand the benefits and risks of carnitine supplementation, particularly in individuals with underlying renal diseases or kidney injury
It helps reduce hunger and manage blood sugar at the same time
But they're formulated to actually work, which we think matters more than aesthetics
/assets/images/provider/photos/2710530.jpg)
